Shannon K Laughlin-Tommaso1,2, Erika L Fuchs3, Melissa F Wellons4, Cora E Lewis5, Ronit Calderon-Margalit6, Elizabeth A Stewart2,7, Pamela J Schreiner8. 1. 1 Division of Gynecology, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota. 2. 2 Department of Surgery, Mayo Clinic, Rochester, Minnesota. 3. 3 Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas. 4. 4 Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. 5. 5 Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. 6. 6 Hadassah-Hebrew University Braun School of Public Health, Jerusalem, Israel . 7. 7 Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota. 8. 8 Division of Epidemiology & Community Health, University of Minnesota, Minneapolis, Minnesota.
Abstract
BACKGROUND: Uterine fibroids, the most common reproductive tract tumor in women, have been associated with hypertension and atherosclerotic cardiovascular disease (CVD). Prior studies of fibroids and CVD have examined the subset of women with symptomatic fibroids who undergo hysterectomy, itself a risk factor for CVD. We aimed to study the risk of subclinical CVD, as determined by coronary artery calcification (CAC), carotid intima media thickness (CIMT), and left ventricular (LV) mass, in women with ultrasound-diagnosed uterine fibroids. MATERIALS AND METHODS: Participants were 972 women from the Coronary Artery Risk Development in Young Adults (CARDIA) study, a cohort recruited in 1985-1986. CARDIA screened black and white women aged 35-49 years by ultrasound for fibroids at 16 years of follow-up (2002-2004). Demographics and CVD risk factors were collected in 2000-2001 at 15 years of follow-up (baseline for this analysis). Women were tested at years 15, 20, and 25 for CAC, at year 20 for CIMT, and at year 25 for echocardiographic LV mass. Multivariable logistic regression was used to estimate the odds of CAC, CIMT, and LV mass. RESULTS: Fifty-two percent of women had fibroids (61.7% in black, 38.3% in white women). Most CVD risk factors were more common in women with fibroids. Adjusted odds of subclinical CVD, such as elevated CIMT and elevated LV mass, were not different for women with fibroids compared with those without (CIMT odds ratio [OR] = 1.03; confidence interval [95% CI] 0.7-1.5 and LV mass OR = 1.14; 95% CI 0.77-1.68), when adjusted for confounders. CONCLUSIONS: Although women with fibroids had more CVD risk factors, presence of fibroids was not associated with subclinical CVD.
BACKGROUND: Uterine fibroids, the most common reproductive tract tumor in women, have been associated with hypertension and atherosclerotic cardiovascular disease (CVD). Prior studies of fibroids and CVD have examined the subset of women with symptomatic fibroids who undergo hysterectomy, itself a risk factor for CVD. We aimed to study the risk of subclinical CVD, as determined by coronary artery calcification (CAC), carotid intima media thickness (CIMT), and left ventricular (LV) mass, in women with ultrasound-diagnosed uterine fibroids. MATERIALS AND METHODS: Participants were 972 women from the Coronary Artery Risk Development in Young Adults (CARDIA) study, a cohort recruited in 1985-1986. CARDIA screened black and white women aged 35-49 years by ultrasound for fibroids at 16 years of follow-up (2002-2004). Demographics and CVD risk factors were collected in 2000-2001 at 15 years of follow-up (baseline for this analysis). Women were tested at years 15, 20, and 25 for CAC, at year 20 for CIMT, and at year 25 for echocardiographic LV mass. Multivariable logistic regression was used to estimate the odds of CAC, CIMT, and LV mass. RESULTS: Fifty-two percent of women had fibroids (61.7% in black, 38.3% in white women). Most CVD risk factors were more common in women with fibroids. Adjusted odds of subclinical CVD, such as elevated CIMT and elevated LV mass, were not different for women with fibroids compared with those without (CIMT odds ratio [OR] = 1.03; confidence interval [95% CI] 0.7-1.5 and LV mass OR = 1.14; 95% CI 0.77-1.68), when adjusted for confounders. CONCLUSIONS: Although women with fibroids had more CVD risk factors, presence of fibroids was not associated with subclinical CVD.
Authors: J Jeffrey Carr; Jennifer Clark Nelson; Nathan D Wong; Michael McNitt-Gray; Yadon Arad; David R Jacobs; Stephan Sidney; Diane E Bild; O Dale Williams; Robert C Detrano Journal: Radiology Date: 2005-01 Impact factor: 11.105
Authors: Shannon K Laughlin-Tommaso; Zaraq Khan; Amy L Weaver; Carin Y Smith; Walter A Rocca; Elizabeth A Stewart Journal: Menopause Date: 2018-05 Impact factor: 2.953
Authors: Minnie Malik; John Norian; Desirée McCarthy-Keith; Joy Britten; William H Catherino Journal: Semin Reprod Med Date: 2010-04-22 Impact factor: 1.303
Authors: Erica E Marsh; Geraldine E Ekpo; Eden R Cardozo; Maureen Brocks; Tanaka Dune; Leeber S Cohen Journal: Fertil Steril Date: 2013-03-15 Impact factor: 7.329
Authors: Mariana Garcia; Virginia M Miller; Martha Gulati; Sharonne N Hayes; JoAnn E Manson; Nanette K Wenger; C Noel Bairey Merz; Rekha Mankad; Amy W Pollak; Jennifer Mieres; Juliana Kling; Sharon L Mulvagh Journal: Mayo Clin Proc Date: 2016-02 Impact factor: 7.616